The U.S. Solution to China's Copper Grab
China consumes 54% of the world's copper. Yet China mines only 8% of its copper needs, while plundering Africa, Latin America and South America for copper. The U.S. is left scrambling for new copper sources. But there's a North American copper sweet spot overlooked by China – for now.
Find Out Where This Copper Hotspot Is

THRX Insider Trading (Theseus Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,528,501.59
Insider Selling (Last 12 Months): $0.00

Theseus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Theseus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theseus Pharmaceuticals Share Price & Price History

Current Price: $7.43
Price Change: Price Decrease of -0.16 (-2.11%)
As of 05/16/2022 05:00 PM ET

This chart shows the closing price history over time for THRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!

Theseus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/21/2022Carl L. GordonDirectorBuy111,896$9.97$1,115,603.12View SEC Filing Icon  
1/19/2022Carl L. GordonDirectorBuy11,521$9.97$114,864.37View SEC Filing Icon  
1/13/2022Carl L. GordonDirectorBuy17,320$9.43$163,327.60View SEC Filing Icon  
1/11/2022Carl L. GordonDirectorBuy8,500$10.51$89,335.00View SEC Filing Icon  
12/21/2021Bradford D. DahmsCFOBuy1,970$10.15$19,995.50View SEC Filing Icon  
12/21/2021Timothy P. ClacksonCEOBuy2,600$9.76$25,376.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for Theseus Pharmaceuticals (NASDAQ:THRX)

90.00% of Theseus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at THRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Theseus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022California State Teachers Retirement System4,926$57K0.0%-22.1%0.013%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP293,587$3.39M0.0%-53.0%0.759%Search for SEC Filing on Google Icon
5/16/2022State Street Corp182,661$2.11M0.0%+44.1%0.472%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.544,855$6.28M0.0%+2.2%1.408%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp29,379$0.34M0.0%+71.2%0.076%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.67,133$0.77M0.0%+19.4%0.173%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund9,495$0.11M0.0%+475.1%0.025%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.533,263$6.76M0.0%N/A1.378%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN6,774$86K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP250,000$3.17M0.0%N/A0.646%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG6,993$89K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System6,325$80K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/15/2022Laurion Capital Management LP205,021$2.60M0.0%N/A0.530%Search for SEC Filing on Google Icon
2/15/2022Lynx1 Capital Management LP409,358$5.19M4.5%N/A1.058%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.761,589$9.66M0.0%N/A1.968%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.22,136$0.28M0.0%N/A0.057%Search for SEC Filing on Google Icon
2/14/2022Boxer Capital LLC892,057$11.31M0.4%N/A2.305%Search for SEC Filing on Google Icon
2/14/2022Nextech Invest AG611,310$7.75M1.8%N/A1.579%Search for SEC Filing on Google Icon
2/14/2022State Street Corp126,796$1.61M0.0%N/A0.328%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC97,500$1.24M0.3%N/A0.252%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC17,494$0.22M0.0%N/A0.045%Search for SEC Filing on Google Icon
2/14/2022Omega Fund Management LLC711,479$9.02M1.3%N/A1.838%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC192,047$2.44M0.0%N/A0.496%Search for SEC Filing on Google Icon
2/11/2022Foresite Capital Opportunity Management V LLC468,820$5.95M4.0%N/A1.211%Search for SEC Filing on Google Icon
2/11/2022Charles Schwab Investment Management Inc.30,944$0.39M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc250,000$3.17M0.0%N/A0.646%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.5,108$65K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.3,147$40K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/10/2022TD Asset Management Inc.56,202$0.71M0.0%N/A0.145%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE7,906$100K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp96,884$1.23M0.0%N/A0.250%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio2,700$34K0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Theseus Pharmaceuticals logo
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Read More on Theseus Pharmaceuticals

Today's Range

Now: $7.43
Low: $7.43
High: $7.78

50 Day Range

MA: $10.96
Low: $7.43
High: $14.51

52 Week Range

Now: $7.43
Low: $7.00
High: $24.54

Volume

26,640 shs

Average Volume

69,061 shs

Market Capitalization

$287.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Theseus Pharmaceuticals?

Theseus Pharmaceuticals' top insider shareholders include:
  1. Bradford D Dahms (CFO)
  2. Carl L Gordon (Director)
  3. Timothy P Clackson (CEO)
Learn More about top insider investors at Theseus Pharmaceuticals.

Who are the major institutional investors of Theseus Pharmaceuticals?

Theseus Pharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 1.41%
  2. Wellington Management Group LLP — 0.76%
  3. State Street Corp — 0.47%
  4. TD Asset Management Inc. — 0.17%
  5. Bank of New York Mellon Corp — 0.08%
  6. New York State Common Retirement Fund — 0.02%
Learn More about top institutional investors of Theseus Pharmaceuticals stock.

Which major investors are selling Theseus Pharmaceuticals stock?

Within the previous quarter, THRX stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. California State Teachers Retirement System

Which major investors are buying Theseus Pharmaceuticals stock?

During the last quarter, THRX stock was purchased by institutional investors including:
  1. State Street Corp
  2. Bank of New York Mellon Corp
  3. BlackRock Inc.
  4. TD Asset Management Inc.
  5. New York State Common Retirement Fund
During the last year, these company insiders have bought Theseus Pharmaceuticals stock:
  1. Bradford D Dahms (CFO)
  2. Carl L Gordon (Director)
  3. Timothy P Clackson (CEO)
Learn More investors buying Theseus Pharmaceuticals stock.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.